{"AllianceGenome": "3239", "HGNC": "3239", "MIM": "129010", "_id": "1959", "_version": 1, "accession": {"genomic": ["AL133417.11", "AL357125.22", "CH471083.1", "CP068268.2", "CQ834156.1", "CQ834160.1", "HI574260.1", "KF459538.1", "KT583897.1", "NC_000010.11", "NC_060934.1", "NG_008936.2", "X53700.1"], "protein": ["AAA52372.1", "AAD24588.1", "AAH35625.1", "ALQ33498.1", "ALQ33499.1", "BAG35671.1", "BAG52349.1", "BAG59400.1", "CAH05293.1", "CAH05295.1", "CAH18435.1", "CBX47619.1", "EAW54238.1", "EAW54239.1", "NP_000390.2", "NP_001129649.1", "NP_001129650.1", "NP_001129651.1", "NP_001307966.1", "NP_001397860.1", "P11161.3", "XP_054220940.1"], "rna": ["AF139463.1", "AK091399.1", "AK296830.1", "AK312813.1", "BC035625.1", "CD370447.1", "CR749641.1", "DA581108.1", "DB242561.1", "J04076.1", "KU178040.1", "KU178041.1", "NM_000399.5", "NM_001136177.3", "NM_001136178.2", "NM_001136179.3", "NM_001321037.2", "NM_001410931.1", "XM_054364965.1"], "translation": [{"protein": "AAD24588.1", "rna": "AF139463.1"}, {"protein": "AAH35625.1", "rna": "BC035625.1"}, {"protein": "BAG35671.1", "rna": "AK312813.1"}, {"protein": "NP_001307966.1", "rna": "NM_001321037.2"}, {"protein": "ALQ33498.1", "rna": "KU178040.1"}, {"protein": "NP_001129649.1", "rna": "NM_001136177.3"}, {"protein": "AAA52372.1", "rna": "J04076.1"}, {"protein": "NP_000390.2", "rna": "NM_000399.5"}, {"protein": "XP_054220940.1", "rna": "XM_054364965.1"}, {"protein": "ALQ33499.1", "rna": "KU178041.1"}, {"protein": "BAG52349.1", "rna": "AK091399.1"}, {"protein": "NP_001129650.1", "rna": "NM_001136178.2"}, {"protein": "CAH18435.1", "rna": "CR749641.1"}, {"protein": "NP_001397860.1", "rna": "NM_001410931.1"}, {"protein": "BAG59400.1", "rna": "AK296830.1"}, {"protein": "NP_001129651.1", "rna": "NM_001136179.3"}]}, "alias": ["AT591", "CMT1D", "CMT4E", "KROX20"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2021-11-17T03:35:16.468Z", "disease_label": "Charcot-Marie-Tooth disease", "gcep": "Charcot-Marie-Tooth Disease Gene Curation Expert Panel", "moi": "SD", "mondo": "MONDO:0015626", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a6e83e27-0c9a-4475-92f5-745303931858-2021-11-17T033516.468Z", "sop": "SOP8"}}, "ensembl": {"gene": "ENSG00000122877", "protein": ["ENSP00000242480", "ENSP00000387634", "ENSP00000490154", "ENSP00000509775", "ENSP00000509830", "ENSP00000510306"], "transcript": ["ENST00000242480", "ENST00000411732", "ENST00000439032", "ENST00000637191", "ENST00000639815", "ENST00000690143", "ENST00000691610"], "translation": [{"protein": "ENSP00000242480", "rna": "ENST00000242480"}, {"protein": "ENSP00000490154", "rna": "ENST00000637191"}, {"protein": "ENSP00000387634", "rna": "ENST00000411732"}, {"protein": "ENSP00000509775", "rna": "ENST00000439032"}, {"protein": "ENSP00000509830", "rna": "ENST00000691610"}, {"protein": "ENSP00000510306", "rna": "ENST00000690143"}], "type_of_gene": "protein_coding"}, "entrezgene": "1959", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 7.04069206, "exp_mis": 201.7473628, "exp_syn": 92.80276, "lof_z": 2.25511520757586, "mis_z": 3.57264360241682, "mu_lof": 5.47430269484e-07, "mu_mis": 1.77321653439e-05, "mu_syn": 8.11675854356e-06, "n_lof": 1.0, "n_mis": 98.0, "n_syn": 77.0, "p_li": 0.619543204134511, "p_null": 0.00779549743094242, "p_rec": 0.372661298434547, "syn_z": 1.01695550770099}, "bp": 1431, "cds_end": 64575789, "cds_start": 64572966, "n_exons": 2, "nonpsych": {"exp_lof": 6.3312346, "exp_mis": 182.5595661, "exp_syn": 83.9541878, "lof_z": 2.08082510059516, "mis_z": 3.52992067402748, "mu_lof": 5.47430269484e-07, "mu_mis": 1.77321653439e-05, "mu_syn": 8.11675854356e-06, "n_lof": 1.0, "n_mis": 88.0, "n_syn": 73.0, "p_li": 0.586229355890158, "p_null": 0.0123356979133756, "p_rec": 0.401434946196467, "syn_z": 0.752701204658165}, "nontcga": {"exp_lof": 6.47341419, "exp_mis": 185.6035649, "exp_syn": 85.37452613, "lof_z": 2.12213426178209, "mis_z": 3.56929411345695, "mu_lof": 5.47430269484e-07, "mu_mis": 1.77321653439e-05, "mu_syn": 8.11675854356e-06, "n_lof": 1.0, "n_mis": 88.0, "n_syn": 68.0, "p_li": 0.577020922733491, "p_null": 0.0110005830232359, "p_rec": 0.411978494243273, "syn_z": 1.19061453506396}, "transcript": "ENST00000242480.3"}, "exons": [{"cdsend": 62816029, "cdsstart": 62813206, "chr": "10", "position": [[62811995, 62814468], [62815860, 62816366]], "strand": -1, "transcript": "NM_000399", "txend": 62816366, "txstart": 62811995}, {"cdsend": 62816029, "cdsstart": 62813206, "chr": "10", "position": [[62811995, 62814468], [62815860, 62816069], [62816252, 62816366]], "strand": -1, "transcript": "NM_001136177", "txend": 62816366, "txstart": 62811995}, {"cdsend": 62816029, "cdsstart": 62813206, "chr": "10", "position": [[62811995, 62814468], [62815860, 62816069], [62818540, 62818647], [62819105, 62819167]], "strand": -1, "transcript": "NM_001136178", "txend": 62819167, "txstart": 62811995}, {"cdsend": 62815879, "cdsstart": 62813206, "chr": "10", "position": [[62811995, 62814468], [62815860, 62815969], [62816069, 62816366]], "strand": -1, "transcript": "NM_001136179", "txend": 62816366, "txstart": 62811995}, {"cdsend": 62815879, "cdsstart": 62813206, "chr": "10", "position": [[62811995, 62814468], [62815860, 62815969], [62816252, 62816366]], "strand": -1, "transcript": "NM_001321037", "txend": 62816366, "txstart": 62811995}], "exons_hg19": [{"cdsend": 64575789, "cdsstart": 64572966, "chr": "10", "position": [[64571755, 64574228], [64575620, 64576126]], "strand": -1, "transcript": "NM_000399", "txend": 64576126, "txstart": 64571755}, {"cdsend": 64575789, "cdsstart": 64572966, "chr": "10", "position": [[64571755, 64574228], [64575620, 64575829], [64576012, 64576126]], "strand": -1, "transcript": "NM_001136177", "txend": 64576126, "txstart": 64571755}, {"cdsend": 64575789, "cdsstart": 64572966, "chr": "10", "position": [[64571755, 64574228], [64575620, 64575829], [64578300, 64578407], [64578865, 64578927]], "strand": -1, "transcript": "NM_001136178", "txend": 64578927, "txstart": 64571755}, {"cdsend": 64575639, "cdsstart": 64572966, "chr": "10", "position": [[64571755, 64574228], [64575620, 64575729], [64575829, 64576126]], "strand": -1, "transcript": "NM_001136179", "txend": 64576126, "txstart": 64571755}, {"cdsend": 64575639, "cdsstart": 64572966, "chr": "10", "position": [[64571755, 64574228], [64575620, 64575729], [64576012, 64576126]], "strand": -1, "transcript": "NM_001321037", "txend": 64576126, "txstart": 64571755}], "generif": [{"pubmed": 11545686, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 11835375, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 11909874, "text": "HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter"}, {"pubmed": 12471219, "text": "Frequency of mutations in the early growth response 2 gene associated with peripheral demyelinating neuropathies"}, {"pubmed": 12471219, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12609493, "text": "EGR2 mutant D355V induces a Cx32 promoter, mutant R381H doesn't. A sequence located at -216, recognized by the wild-type and the mutant D355V recombinant proteins, is relevant for promoter transactivation."}, {"pubmed": 12687019, "text": "we found that EGR2 could induce apoptosis in a large proportion of these lines by altering the permeability of mitochondrial membranes, releasing cytochrome c and activating caspase-3, -8, and -9."}, {"pubmed": 12736090, "text": "This report detected a heterozygous Asp383Tyr mutation of EGR2 in one patient with severe CMT1, Dejerine-Sottas syndrome."}, {"pubmed": 14596916, "text": "a possible molecular mechanism to account for down-regulation of EGR2 in tumor cells"}, {"pubmed": 15173177, "text": "Egr-2 and Egr-3 transcription is enhanced by Hepatitis B virus X protein, which induces fasL gene expression"}, {"pubmed": 15947997, "text": "A Charcot-Marie-Tooth syndrome in a family with a missense mutation in EGR2."}, {"pubmed": 16198564, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16198564, "text": "One novel de-novo mutation (Arg359Gln, R359Q) was identified in heterozygous state in a patient with a typical CMT1 phenotype, progressive moderate thoracolumbar scoliosis and without clinical signs of cranial nerve dysfunction."}, {"pubmed": 16495311, "text": "Control of Krox20 transcription relies on three very long-range enhancer elements (A, B and C) that are conserved in chick, mouse and human genomes."}, {"pubmed": 16912585, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17717711, "text": "morphological studies in the context of the I268N homozygous recessive mutation affecting the NAB repressor binding site and the R359W dominant-negative mutation in the zinc-finger domain"}, {"pubmed": 18678671, "text": "Collectively, these data indicate that EGR2 is specifically upregulated by a parasite-derived secreted factor that is most likely a resident rhoptry protein."}, {"pubmed": 19000991, "text": "Dysregulation of EGR2 and MeCP2 plays roles in in Rett syndrome and autism."}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19651900, "text": "AIP2 regulates activation-induced T-cell death by suppressing EGR2-mediated FasL expression via the ubiquitin pathway"}, {"pubmed": 20067763, "text": "overexpression of miR-150 in gastric cancer could promote proliferation and growth of cancer cells at least partially through directly targeting the tumor-suppressor EGR2."}, {"pubmed": 20144677, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20194224, "text": "EGR2 is a genetic risk factor for Systemic lupus erythematosus (SLE), in which increased gene expression may contribute to SLE pathogenesis."}, {"pubmed": 20194224, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20379146, "text": "Observational study and genome-wide association study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20506119, "text": "Results suggest that in many cells of neuroectodermal and epithelial origin EGR1, EGR2, and EGR3 activate NAB2 transcription which is in turn repressed by NAB2, thus establishing a negative feedback loop."}, {"pubmed": 20513111, "text": "EGR2 mutation(amino aacid substitution) identifies a case of Charcot-Marie-Totth disease."}, {"pubmed": 20628624, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20687139, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21042708, "text": "EGR2 is a direct transcriptional target of p53 family that can in part mediate the p53-dependent apoptotic pathway."}, {"pubmed": 21057508, "text": "Schwann cells expressed myelin proteins and Krox20 which is an important regulator of peripheral myelination."}, {"pubmed": 21479245, "text": "These data define serum response factor as a host cell transcription factor that regulates immediate early gene expression in Toxoplasma-infected cells."}, {"pubmed": 21514423, "text": "these findings suggest that Egr-2 plays an important nonredundant role in the pathogenesis of fibrosis."}, {"pubmed": 21703609, "text": "TGF-beta3 regulated Egr-2 gene expression in uterine leiomyoma cells."}, {"pubmed": 21836637, "text": "Krox20 functions as a SUMO ligase for its coregulators--the Nab proteins--and that Nab sumoylation negatively modulates Krox20 transcriptional activity in vivo."}, {"pubmed": 22089088, "text": "Combined with a plausible biological function of EGR2, the EGR2 gene is a possible susceptibility gene in bipolar disorder."}, {"pubmed": 22271166, "text": "Results identify a mutation in EGR2 in a Charcot-Marie-tooth disease patient with hypersensitivity to vincristine."}, {"pubmed": 22327514, "text": "Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma."}, {"pubmed": 22522483, "text": "data further demonstrate the major role of the myelinating Schwann cell element in the regulation of EGR2 expression in the human peripheral nervous system"}, {"pubmed": 22546699, "text": "Charcot-Marie-Tooth neuropathy due to a novel EGR2 gene mutation exhibits a mild phenotype in a Czech family."}, {"pubmed": 22691714, "text": "data suggest a tendency of gender-specific association of EGR2 and EGR4 in schizophrenia."}, {"pubmed": 22734907, "text": "we report on a heterozygous mutation in EGR2 in a family with a mild demyelinating form of adult-onset Charcot-Marie-Tooth disease"}, {"pubmed": 22765307, "text": "In Greek Charcot-Marie-Tooth type 1 patients, 3 pathogenic mutations were found (3.5%); two recently reported micromutations in PMP22 3, and one known point mutation in EGR2"}, {"pubmed": 22915601, "text": "Egr2 expression is translationally regulated via an IRES element, which is responsive to an inflammatory environment."}, {"pubmed": 23485457, "text": "EGR2 and EGR3 are regulated by NFkappaB and MAPK signalling pathways downstream of TNFalpha stimulation in breast adipose fibroblasts, and this in turn is upstream of CYP19A1 transcription via PI.4"}, {"pubmed": 23747400, "text": "Lack of association of EGR2 variants with bipolar disorder in Japanese population."}, {"pubmed": 23924943, "text": "Overexpression of EGR2 significantly attenuated the oncogenic effect of miR-20a."}, {"pubmed": 24007274, "text": "transcription factor early growth response gene-2 is a novel molecular switch regulating known immunomodulatory molecules in human mesenchymal stem cells."}, {"pubmed": 25381473, "text": "Dysregulated Egr-2 is observed in some human autoimmune disorders."}, {"pubmed": 25548232, "text": "our data suggest that robust CD26 costimulatory signaling induces preferential expression of EGR2 and IL-10 as a potential mechanism for regulating CD26-mediated activation."}, {"pubmed": 25935837, "text": "Knock-down of EGR2 with siRNA was demonstrated to have a similar effect as the over-expression of miR-330-3p in NSCLC cell lines"}, {"pubmed": 26119399, "text": "A recurrent mutation was identified in EGR2 which appears to be associated with the pathogenesis of schizophrenia."}, {"pubmed": 26204789, "text": "EGR2 mutation presents as an axonal Charcot-Marie-Tooth phenotype with variable severity."}, {"pubmed": 26214589, "text": "EGR2 knockdown inhibited proliferation, clonogenicity and spheroidal growth in vitro and induced regression of Ewing sarcoma xenografts."}, {"pubmed": 26238942, "text": "MicroRNA20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing EGR2 expression."}, {"pubmed": 26718337, "text": "These results suggested that EGR2 overexpression has a pivotal role in the downregulation of cytokines implicated in the pathophysiology of Guillain-Barre syndrome"}, {"pubmed": 27667480, "text": "In the PPI network, genes may be involved in Down syndrome (DS) by interacting with others, including nuclear receptor subfamily 4 group A member 2 (NR4A2)early growth response (EGR)2 and NR4A2EGR3. Therefore, RUNX1, NR4A2, EGR2, EGR3 and ID4 may be key genes associated with the pathogenesis of DS."}, {"pubmed": 27856665, "text": "Egr2 and Egr3 have emerged as regulatory molecules that suppress excessive immune responses. Mice deficient for Egr2 and Egr3 develop a lupus-like disease with dysregulated activation of effector T cells. Egr2 and Egr3 confer suppressive activity to CD4(+) T cells and regulate the production of inhibitory cytokines such as IL-10 and TGF-beta1."}, {"pubmed": 27890615, "text": "Analysis of consensus EGR-binding elements (EBEs) showed that the immediate early response 3 gene (IER3) is a novel transcriptional target gene of EGR2 as confirmed by the luciferase assay, electrophoretic mobility-shift assay (EMSA), chromatin immunoprecipitation (ChIP), and western blot analysis."}, {"pubmed": 28115575, "text": "Egr2-driven cell surface proteins LAG-3 and 4-1BB can identify dysfunctional tumor antigen-specific CD8(+) TIL."}, {"pubmed": 28542387, "text": "Low EGR2 expression is associated with hepatocellular carcinoma."}, {"pubmed": 28576496, "text": "The study suggests that acetylation of EGR2 is regulated independently of nucleosome remodeling and deacetylase."}, {"pubmed": 29535721, "text": "LAG3(+) Tregs suppress humoral immune responses via transforming growth factor beta3 production in an Egr2- and Egr3-dependent manner."}, {"pubmed": 31298399, "text": "LncRNA MEG3 aggravates palmitate-induced insulin resistance by regulating miR-185-5p/Egr2 axis in hepatic cells."}, {"pubmed": 31692087, "text": "expression in tendon cells appeared to be sensitive to overloading and unloading but did not respond to the single episode of physiologic-range loading"}, {"pubmed": 32432752, "text": "MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma."}, {"pubmed": 32507977, "text": "Downregulation of miR-140-5p affects the pathogenesis of HSCR by targeting EGR2."}, {"pubmed": 32672815, "text": "Egr2-guided histone H2B monoubiquitination is required for peripheral nervous system myelination."}, {"pubmed": 32896048, "text": "Bi-allelic mutations in EGR2 cause autosomal recessive demyelinating neuropathy by disrupting the EGR2-NAB complex."}, {"pubmed": 33023539, "text": "NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression."}, {"pubmed": 33547862, "text": "Early growth response 2 (EGR2) is a novel regulator of the senescence programme."}, {"pubmed": 33692344, "text": "The epigenetic pioneer EGR2 initiates DNA demethylation in differentiating monocytes at both stable and transient binding sites."}, {"pubmed": 33973090, "text": "EGR1/2 Inhibits Papillary Thyroid Carcinoma Cell Growth by Suppressing the Expression of PTEN and BAX."}, {"pubmed": 34130587, "text": "MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2)."}, {"pubmed": 34326314, "text": "EGR2-mediated regulation of m(6)A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization."}, {"pubmed": 34797692, "text": "The transcription factor EGR2 is indispensable for tissue-specific imprinting of alveolar macrophages in health and tissue repair."}, {"pubmed": 35770518, "text": "EGR2-related mixed demyelinating and axonal Charcot-Marie-Tooth disease: An electrodiagnostic, nerve imaging, and histological study."}, {"pubmed": 36342511, "text": "Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells."}, {"pubmed": 36987665, "text": "Temozolomide protects against the progression of glioblastoma via SOX4 downregulation by inhibiting the LINC00470-mediated transcription factor EGR2."}, {"pubmed": 37011008, "text": "Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction."}, {"pubmed": 37306961, "text": "EGR2 gene-linked hereditary neuropathies present with a bimodal age distribution at symptoms onset."}, {"pubmed": 37443284, "text": "Transcription factor EGR2 controls homing and pathogenicity of TH17 cells in the central nervous system."}, {"pubmed": 37474655, "text": "EGR2 drives TH17 cell pathogenicity in autoimmune neuroinflammation."}, {"pubmed": 38165680, "text": "MicroRNA-150-5P regulates Th1/Th2 cytokines expression levels by targeting EGR2 in allergic rhinitis."}, {"pubmed": 38679230, "text": "Early growth response protein 2 promotes partial epithelial-mesenchymal transition by phosphorylating Smad3 during renal fibrosis."}], "genomic_pos": {"chr": "10", "end": 62819167, "ensemblgene": "ENSG00000122877", "start": 62811996, "strand": -1}, "genomic_pos_hg19": {"chr": "10", "end": 64679660, "start": 64571756, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006611", "qualifier": "involved_in", "term": "protein export from nucleus"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007420", "pubmed": 9537424, "qualifier": "involved_in", "term": "brain development"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007422", "pubmed": 9537424, "qualifier": "involved_in", "term": "peripheral nervous system development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007611", "qualifier": "involved_in", "term": "learning or memory"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007622", "qualifier": "involved_in", "term": "rhythmic behavior"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008045", "qualifier": "involved_in", "term": "motor neuron axon guidance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010467", "qualifier": "involved_in", "term": "gene expression"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0014037", "qualifier": "involved_in", "term": "Schwann cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0014040", "qualifier": "involved_in", "term": "positive regulation of Schwann cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016925", "qualifier": "involved_in", "term": "protein sumoylation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0016925", "qualifier": "involved_in", "term": "protein sumoylation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021612", "qualifier": "involved_in", "term": "facial nerve structural organization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021659", "qualifier": "involved_in", "term": "rhombomere 3 structural organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021660", "qualifier": "involved_in", "term": "rhombomere 3 formation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021665", "qualifier": "involved_in", "term": "rhombomere 5 structural organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021666", "qualifier": "involved_in", "term": "rhombomere 5 formation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030278", "qualifier": "involved_in", "term": "regulation of ossification"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0031643", "qualifier": "involved_in", "term": "positive regulation of myelination"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032868", "qualifier": "involved_in", "term": "response to insulin"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035284", "qualifier": "involved_in", "term": "brain segmentation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035904", "qualifier": "involved_in", "term": "aorta development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035914", "qualifier": "involved_in", "term": "skeletal muscle cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042552", "qualifier": "involved_in", "term": "myelination"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045444", "qualifier": "involved_in", "term": "fat cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045893", "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": [12687019, 17717711], "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048168", "qualifier": "involved_in", "term": "regulation of neuronal synaptic plasticity"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005634", "pubmed": 14532282, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005634", "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005737", "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "located_in", "term": "intracellular membrane-bounded organelle"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0000976", "qualifier": "enables", "term": "transcription cis-regulatory region binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": 12687019, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000981", "pubmed": 17717711, "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 12687019, "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISS", "id": "GO:0003682", "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003700", "pubmed": 14532282, "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 14532282, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0031625", "pubmed": 19651900, "qualifier": "enables", "term": "ubiquitin protein ligase binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0043565", "pubmed": 17717711, "qualifier": "enables", "term": "sequence-specific DNA binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0061629", "qualifier": "enables", "term": "RNA polymerase II-specific DNA-binding transcription factor binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0061665", "qualifier": "enables", "term": "SUMO ligase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0071837", "qualifier": "enables", "term": "HMG box domain binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 30190], [8364, 100101746], [9544, 698132], [9598, 745846], [9606, 1959], [9615, 479219], [9913, 100297981], [10090, 13654], [10116, 114090]], "id": 20123}, "interpro": [{"desc": "Zinc finger C2H2-type", "id": "IPR013087", "short_desc": "Znf_C2H2_type"}, {"desc": "Early growth response, N-terminal", "id": "IPR021849", "short_desc": "EGR_N"}, {"desc": "Zinc finger C2H2 superfamily", "id": "IPR036236", "short_desc": "Znf_C2H2_sf"}], "ipi": ["IPI00305368", "IPI00797785"], "map_location": "10q21.3", "name": "early growth response 2", "other_names": ["E3 SUMO-protein ligase EGR2", "E3 SUMO-protein transferase ERG2", "KROX-20, Drosophila, homolog (early growth response-2)", "early growth response protein 2", "zinc finger protein Krox-20"], "pantherdb": {"HGNC": "3239", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95296", "ortholog_type": "LDO", "panther_family": "PTHR23235", "taxid": 10090, "uniprot_kb": "P08152"}, {"RGD": "621608", "ortholog_type": "LDO", "panther_family": "PTHR23235", "taxid": 10116, "uniprot_kb": "P51774"}, {"Ensembl": "ENSGALG00000040971", "ortholog_type": "LDO", "panther_family": "PTHR23235", "taxid": 9031, "uniprot_kb": "Q98T82"}, {"ZFIN": "ZDB-GENE-980526-283", "ortholog_type": "LDO", "panther_family": "PTHR23235", "taxid": 7955, "uniprot_kb": "Q05159"}, {"WormBase": "WBGene00007772", "ortholog_type": "O", "panther_family": "PTHR23235", "taxid": 6239, "uniprot_kb": "Q18250"}, {"WormBase": "WBGene00043705", "ortholog_type": "O", "panther_family": "PTHR23235", "taxid": 6239, "uniprot_kb": "U4PBA8"}, {"FlyBase": "FBgn0003499", "ortholog_type": "O", "panther_family": "PTHR23235", "taxid": 7227, "uniprot_kb": "A0A0B4KGW2"}], "uniprot_kb": "P11161"}, "pathway": {"kegg": [{"id": "hsa04625", "name": "C-type lectin receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa05161", "name": "Hepatitis B - Homo sapiens (human)"}, {"id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05203", "name": "Viral carcinogenesis - Homo sapiens (human)"}], "pid": [{"id": "il4_2pathway", "name": "IL4-mediated signaling events"}, {"id": "nfat_tfpathway", "name": "Calcineurin-regulated NFAT-dependent transcription in lymphocytes"}, {"id": "tap63pathway", "name": "Validated transcriptional targets of TAp63 isoforms"}], "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-166520", "name": "Signaling by NTRKs"}, {"id": "R-HSA-187037", "name": "Signaling by NTRK1 (TRKA)"}, {"id": "R-HSA-187037", "name": "Signaling by NTRK1 (TRKA)"}, {"id": "R-HSA-198725", "name": "Nuclear Events (kinase and transcription factor activation)"}, {"id": "R-HSA-198725", "name": "Nuclear Events (kinase and transcription factor activation)"}, {"id": "R-HSA-381340", "name": "Transcriptional regulation of white adipocyte differentiation"}, {"id": "R-HSA-5617472", "name": "Activation of anterior HOX genes in hindbrain development during early embryogenesis"}, {"id": "R-HSA-5619507", "name": "Activation of HOX genes during differentiation"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9031628", "name": "NGF-stimulated transcription"}, {"id": "R-HSA-9031628", "name": "NGF-stimulated transcription"}, {"id": "R-HSA-9619665", "name": "EGR2 and SOX10-mediated initiation of Schwann cell myelination"}, {"id": "R-HSA-9619665", "name": "EGR2 and SOX10-mediated initiation of Schwann cell myelination"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9843745", "name": "Adipogenesis"}], "wikipathways": [{"id": "WP236", "name": "Adipogenesis"}, {"id": "WP2380", "name": "Brain-derived neurotrophic factor (BDNF) signaling pathway"}, {"id": "WP4149", "name": "White fat cell differentiation"}, {"id": "WP4211", "name": "Transcriptional cascade regulating adipogenesis"}, {"id": "WP4666", "name": "Hepatitis B infection"}, {"id": "WP4856", "name": "Intracellular trafficking proteins involved in CMT neuropathy"}]}, "pfam": ["PF00096", "PF11928"], "pharmgkb": "PA27674", "pharos": {"target_id": 9775, "tdl": "Tbio"}, "prosite": "PS50157", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248839", "relationship": "is"}, {"id": "GNF248840", "relationship": "is"}, {"id": "GNF248841", "relationship": "is"}, {"id": "GNF248842", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF162903", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF037043", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082004", "relationship": "is"}, {"id": "GNF082005", "relationship": "is"}, {"id": "GNF082006", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051489", "relationship": "is"}, {"id": "GNF056253", "relationship": "is"}, {"id": "GNF060996", "relationship": "is"}, {"id": "GNF078870", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070007", "relationship": "is"}, {"id": "GNF070008", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF004047", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF238664", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098750", "relationship": "is"}, {"id": "GNF138405", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000010.11", "NC_060934.1", "NG_008936.2"], "protein": ["NP_000390.2", "NP_001129649.1", "NP_001129650.1", "NP_001129651.1", "NP_001307966.1", "NP_001397860.1", "XP_054220940.1"], "rna": ["NM_000399.5", "NM_001136177.3", "NM_001136178.2", "NM_001136179.3", "NM_001321037.2", "NM_001410931.1", "XM_054364965.1"], "translation": [{"protein": "NP_001307966.1", "rna": "NM_001321037.2"}, {"protein": "NP_001129649.1", "rna": "NM_001136177.3"}, {"protein": "NP_000390.2", "rna": "NM_000399.5"}, {"protein": "XP_054220940.1", "rna": "XM_054364965.1"}, {"protein": "NP_001129650.1", "rna": "NM_001136178.2"}, {"protein": "NP_001397860.1", "rna": "NM_001410931.1"}, {"protein": "NP_001129651.1", "rna": "NM_001136179.3"}]}, "reporter": {"HG-U133_Plus_2": "205249_at", "HG-U95Av2": "37863_at", "HTA-2_0": "TC10001327.hg.1", "HuEx-1_0": "3291601", "HuGene-1_1": "7933872", "HuGene-2_1": "16714776"}, "summary": "The protein encoded by this gene is a transcription factor with three tandem C2H2-type zinc fingers. Defects in this gene are associated with Charcot-Marie-Tooth disease type 1D (CMT1D), Charcot-Marie-Tooth disease type 4E (CMT4E), and with Dejerine-Sottas syndrome (DSS). Multiple transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].", "symbol": "EGR2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414315"}, "unigene": "Hs.1395", "uniprot": {"Swiss-Prot": "P11161", "TrEMBL": ["A0A8I5KVU0", "A0A8I5KYI5", "A0A8I5QL03"]}, "wikipedia": {"url_stub": "EGR2"}}